论文部分内容阅读
目的研究反复呼吸道感染患儿服用匹多莫德口服液的临床效果。方法选2012年3月至2013年3月于我院儿科反复呼吸道感染治疗的患儿80例,随机分为治疗组47例和对照组40例,对照组采取常规的治疗方式,治疗组在采取常规治疗的前提下服用匹多莫德口服液。两组的疗程均为8周,治疗结束后要对全部患者进行为期6个月的随访,记录患者用药后的病情以及发生呼吸道感染的次数等情况。结果治疗组高达93.6%的总有效率远远大于对照组62.5%的总有效率,两组之间存在显著差异,具有统计学意义(P<0.05)。结论小儿反复呼吸道感染患者采取常规治疗加匹多莫德口服液的方式效果显著,治疗过程无任何不良反应,值得临床推广。
Objective To study the clinical effect of taking pidotiline in children with recurrent respiratory tract infection. Methods Eighty children with pediatric recurrent respiratory tract infections in our hospital from March 2012 to March 2013 were randomly divided into treatment group (n = 47) and control group (n = 40). The control group was given conventional treatment and the treatment group The usual treatment of taking Pidotimod oral solution. Both groups were treated for 8 weeks. After the treatment, all patients should be followed up for 6 months. The patient’s medical condition and the number of respiratory infections should be recorded. Results The total effective rate of up to 93.6% in the treatment group was far greater than the total effective rate of 62.5% in the control group, with significant difference between the two groups (P <0.05). Conclusion The treatment of children with recurrent respiratory tract infection with conventional treatment of pidotimod oral solution has a significant effect, no adverse reactions in the course of treatment, is worth clinical promotion.